Parents’ Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders

Carly L. Roberts, Lara J. Farrell*, Allison M. Waters, Ella L. Oar, Thomas H. Ollendick

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

This study aimed to examine parents’ perceptions of established treatments, including cognitive behaviour therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), relative to novel treatments of d-cycloserine (DCS) and attention bias modification (ABM) augmented CBT to determine if novel treatments are perceived as more or less favorable than established treatments. Participants included parents of children with a specific phobia, enrolled in one of two randomized controlled trials of either one-session augmented DCS (n = 38, Gold Coast) or ABM augmented one-session treatment (n = 34, Brisbane), as well as parents from a community sample (n = 38). Parents of children with a specific phobia perceived CBT most favorably. There was no difference between the sites on perceptions of ABM. However, parents of children enrolled in the DCS trial perceived DCS more favorably than parents of children enrolled in the ABM trial and the community sample. These results demonstrate parents’ greater acceptance of psychological treatments over pharmacological treatments for the treatment of childhood phobias, highlighting the importance of educating parents to novel treatments.

Original languageEnglish
Pages (from-to)459-471
Number of pages13
JournalChild Psychiatry and Human Development
Volume47
Issue number3
DOIs
Publication statusPublished - 1 Jun 2016
Externally publishedYes

Fingerprint Dive into the research topics of 'Parents’ Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders'. Together they form a unique fingerprint.

Cite this